Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Data, Statistics and Legislation
  3. Prescription Drug Price Transparency
Topic Menu

Prescription Drug Price Transparency

  • Prescription Drug Price Transparency Home
  • Announcements
  • Drugs of Substantial Public Interest Lists
  • Reporting Resources
    • Manufacturers
    • Wholesalers
    • Pharmacies
    • PBMs
  • Research and Analysis
    • Data and Dashboards
    • Publications

Related Sites

  • Health Economics Program
  • 340B Covered Entity Report
  • Accessible Prescription Drug Labels
  • Rx Data Portal Resources

Prescription Drug Price Transparency

  • Prescription Drug Price Transparency Home
  • Announcements
  • Drugs of Substantial Public Interest Lists
  • Reporting Resources
    • Manufacturers
    • Wholesalers
    • Pharmacies
    • PBMs
  • Research and Analysis
    • Data and Dashboards
    • Publications

Related Sites

  • Health Economics Program
  • 340B Covered Entity Report
  • Accessible Prescription Drug Labels
  • Rx Data Portal Resources
Contact Info
Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Contact Info

Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Prescription Drug Price Transparency
Reporting Information for Pharmacy Benefit Managers

Pharmacy Benefit Managers (PBMs) that are licensed in Minnesota are required to report information on drug prices to the Minnesota Department of Health (MDH) under the Drugs of Substantial Public Interest provision of the Act (Minnesota Statues 62J.84, subd. 14). This page provides specific guidance on reporting for pharmacies.

Rx Data Portal 

PBMs must register and submit reports to MDH using the Rx Data Portal. For technical guidance on using the Rx Data Portal, including information on how to register and manage accounts, visit the Rx Data Portal Resources page.

Reporting Guidance

  • Prescription Drug Price Transparency Act Form and Manner Document (PDF) (updated January 2025)— for requirements on the form and manner for reporting under the Act.

  • Prescription Drug Price Transparency FAQ (coming soon)— for answers to some common questions about reporting under the Act.

  • Drugs of Substantial Public Interest Lists page – for new Drugs of Substantial Public Interest list announcements.

Key Questions for PBMs

For Drugs of Substantial Public Interest reporting, MDH publishes the lists of drugs for reporting online and will notify registered PBMs of the drugs requiring reporting. All lists posted by MDH are available on the Drugs of Substantial Public Interest Lists page. 

Yes. All PBMs licensed in Minnesota need to register using the Rx Data Portal. For technical guidance on using the Rx Data Portal, including information on how to register and manage accounts, visit the Rx Data Portal Resources page.

PBMs must use the Rx Data Portal for all submissions. Reporting templates are available for download within the portal.

Tags
  • rx transparency
Last Updated: 11/06/2025

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube